CN103201380A - 新岩藻糖基转移酶及它们的应用 - Google Patents
新岩藻糖基转移酶及它们的应用 Download PDFInfo
- Publication number
- CN103201380A CN103201380A CN2011800490185A CN201180049018A CN103201380A CN 103201380 A CN103201380 A CN 103201380A CN 2011800490185 A CN2011800490185 A CN 2011800490185A CN 201180049018 A CN201180049018 A CN 201180049018A CN 103201380 A CN103201380 A CN 103201380A
- Authority
- CN
- China
- Prior art keywords
- sugar
- polypeptide
- oligosaccharides
- albumen
- fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010019236 Fucosyltransferases Proteins 0.000 title description 22
- 102000006471 Fucosyltransferases Human genes 0.000 title description 21
- 108010001671 galactoside 3-fucosyltransferase Proteins 0.000 claims abstract description 60
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 44
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 42
- 238000000034 method Methods 0.000 claims abstract description 36
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 30
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 18
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 18
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 18
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 72
- 235000000346 sugar Nutrition 0.000 claims description 66
- 229920001184 polypeptide Polymers 0.000 claims description 61
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 61
- 108091033319 polynucleotide Proteins 0.000 claims description 48
- 102000040430 polynucleotide Human genes 0.000 claims description 48
- 239000002157 polynucleotide Substances 0.000 claims description 47
- 239000000758 substrate Substances 0.000 claims description 45
- 230000033581 fucosylation Effects 0.000 claims description 37
- 230000000694 effects Effects 0.000 claims description 29
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 21
- 239000008101 lactose Substances 0.000 claims description 21
- 235000001014 amino acid Nutrition 0.000 claims description 18
- 125000003729 nucleotide group Chemical group 0.000 claims description 18
- 239000002773 nucleotide Substances 0.000 claims description 17
- 150000001413 amino acids Chemical class 0.000 claims description 16
- 125000002446 fucosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)[C@@H](O1)C)* 0.000 claims description 13
- 238000000926 separation method Methods 0.000 claims description 12
- 102000004190 Enzymes Human genes 0.000 claims description 11
- 108090000790 Enzymes Proteins 0.000 claims description 11
- LQEBEXMHBLQMDB-UHFFFAOYSA-N GDP-L-fucose Natural products OC1C(O)C(O)C(C)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C3=C(C(N=C(N)N3)=O)N=C2)O1 LQEBEXMHBLQMDB-UHFFFAOYSA-N 0.000 claims description 11
- LQEBEXMHBLQMDB-JGQUBWHWSA-N GDP-beta-L-fucose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C3=C(C(NC(N)=N3)=O)N=C2)O1 LQEBEXMHBLQMDB-JGQUBWHWSA-N 0.000 claims description 11
- 238000009396 hybridization Methods 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 230000012010 growth Effects 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 108020004705 Codon Proteins 0.000 claims description 7
- 238000006555 catalytic reaction Methods 0.000 claims description 7
- 239000012634 fragment Substances 0.000 claims description 7
- 241000588724 Escherichia coli Species 0.000 claims description 6
- 108700028369 Alleles Proteins 0.000 claims description 5
- 241000196324 Embryophyta Species 0.000 claims description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 claims description 4
- 230000000295 complement effect Effects 0.000 claims description 4
- 241000233866 Fungi Species 0.000 claims description 3
- 230000004060 metabolic process Effects 0.000 claims description 3
- 238000003499 nucleic acid array Methods 0.000 claims description 3
- 235000016709 nutrition Nutrition 0.000 claims description 3
- 241000238631 Hexapoda Species 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims description 2
- 230000000968 intestinal effect Effects 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 18
- 241000606124 Bacteroides fragilis Species 0.000 abstract description 14
- 241000702462 Akkermansia muciniphila Species 0.000 abstract description 6
- 150000002632 lipids Chemical class 0.000 abstract description 5
- 102000004169 proteins and genes Human genes 0.000 abstract description 2
- AUNPEJDACLEKSC-ZAYDSPBTSA-N 3-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O[C@H](CO)[C@@H]1O AUNPEJDACLEKSC-ZAYDSPBTSA-N 0.000 abstract 1
- WJPIUUDKRHCAEL-UHFFFAOYSA-N 3FL Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)OC(O)C1O WJPIUUDKRHCAEL-UHFFFAOYSA-N 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 44
- 229940024606 amino acid Drugs 0.000 description 17
- 102000005962 receptors Human genes 0.000 description 17
- 108020003175 receptors Proteins 0.000 description 17
- 108020004414 DNA Proteins 0.000 description 15
- 230000014509 gene expression Effects 0.000 description 15
- 239000000047 product Substances 0.000 description 14
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 12
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 12
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 12
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 12
- 238000005516 engineering process Methods 0.000 description 10
- 230000004048 modification Effects 0.000 description 10
- 238000012986 modification Methods 0.000 description 10
- 101100013697 Drosophila melanogaster FucT6 gene Proteins 0.000 description 8
- 241000590002 Helicobacter pylori Species 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229940037467 helicobacter pylori Drugs 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- 102000051366 Glycosyltransferases Human genes 0.000 description 4
- 108700023372 Glycosyltransferases Proteins 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- -1 semi-lactosi Chemical compound 0.000 description 4
- 238000001890 transfection Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical group OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- KFEUJDWYNGMDBV-UHFFFAOYSA-N (N-Acetyl)-glucosamin-4-beta-galaktosid Natural products OC1C(NC(=O)C)C(O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 KFEUJDWYNGMDBV-UHFFFAOYSA-N 0.000 description 2
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- FPWYUEKIRUBHML-LGVAUZIVSA-N 2-amino-9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purin-6-one;phosphoric acid Chemical compound OP(O)(O)=O.OP(O)(O)=O.C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O FPWYUEKIRUBHML-LGVAUZIVSA-N 0.000 description 2
- 230000005730 ADP ribosylation Effects 0.000 description 2
- 241000244203 Caenorhabditis elegans Species 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 108010045674 Fucose-1-phosphate guanylyltransferase Proteins 0.000 description 2
- 102100037047 Fucose-1-phosphate guanylyltransferase Human genes 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 102100040648 L-fucose kinase Human genes 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 2
- KFEUJDWYNGMDBV-LODBTCKLSA-N N-acetyllactosamine Chemical compound O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KFEUJDWYNGMDBV-LODBTCKLSA-N 0.000 description 2
- HESSGHHCXGBPAJ-UHFFFAOYSA-N N-acetyllactosamine Natural products CC(=O)NC(C=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O HESSGHHCXGBPAJ-UHFFFAOYSA-N 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 241000242680 Schistosoma mansoni Species 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 108020004566 Transfer RNA Proteins 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 108010083136 fucokinase Proteins 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 238000012239 gene modification Methods 0.000 description 2
- 230000005017 genetic modification Effects 0.000 description 2
- 235000013617 genetically modified food Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 230000033444 hydroxylation Effects 0.000 description 2
- 238000005805 hydroxylation reaction Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 101150066555 lacZ gene Proteins 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N pentanoic acid group Chemical group C(CCCC)(=O)O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 description 1
- 108010083651 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase Proteins 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 241000702460 Akkermansia Species 0.000 description 1
- 101710153593 Albumin A Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000423333 Bacteroides fragilis NCTC 9343 Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 108010092694 L-Selectin Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 102000016551 L-selectin Human genes 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241001138501 Salmonella enterica Species 0.000 description 1
- CWHJIJJSDGEHNS-MYLFLSLOSA-N Senegenin Chemical compound C1[C@H](O)[C@H](O)[C@@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)C(CC[C@]4(CCC(C[C@H]44)(C)C)C(O)=O)=C4[C@@H](CCl)C[C@@H]3[C@]21C CWHJIJJSDGEHNS-MYLFLSLOSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 101001134239 Trigonella foenum-graecum Protein MANNAN SYNTHESIS-RELATED Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000006035 Tryptophane Substances 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- OMOVVBIIQSXZSZ-UHFFFAOYSA-N [6-(4-acetyloxy-5,9a-dimethyl-2,7-dioxo-4,5a,6,9-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl)-5-formyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-hydroxy-3-methylpentanoate Chemical compound CC12C(OC(=O)C(O)C(C)CC)C(OC=O)C(C3(C)C(CC(=O)OC4(C)COC(=O)CC43)OC(C)=O)C(=C)C32OC3CC1C=1C=COC=1 OMOVVBIIQSXZSZ-UHFFFAOYSA-N 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 239000012431 aqueous reaction media Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000021523 carboxylation Effects 0.000 description 1
- 238000006473 carboxylation reaction Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000000909 electrodialysis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000022244 formylation Effects 0.000 description 1
- 238000006170 formylation reaction Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 230000006122 isoprenylation Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000007498 myristoylation Effects 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229940067626 phosphatidylinositols Drugs 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000021309 simple sugar Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000019635 sulfation Effects 0.000 description 1
- 238000005670 sulfation reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000009871 tenuigenin Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000010023 transfer printing Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000005866 tritylation reaction Methods 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01214—Glycoprotein 3-alpha-L-fucosyltransferase (2.4.1.214)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
岩藻糖基转移酶 | 产量3-FL[mM] |
无(阴性对照) | 0 |
FutA(幽门螺杆菌) | 3,83 |
Amuc0760co(Akkermansia muciniphila) | 5,39 |
FucT6(脆弱拟杆菌) | 4,95 |
FucT7(脆弱拟杆菌) | 6,89 |
Claims (16)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10187167.1A EP2439264B1 (en) | 2010-10-11 | 2010-10-11 | Novel fucosyltransferases and their applications |
EP10187167.1 | 2010-10-11 | ||
PCT/EP2011/067538 WO2012049083A2 (en) | 2010-10-11 | 2011-10-07 | Novel fucosyltransferases and their applications |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103201380A true CN103201380A (zh) | 2013-07-10 |
CN103201380B CN103201380B (zh) | 2018-07-24 |
Family
ID=43244921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180049018.5A Active CN103201380B (zh) | 2010-10-11 | 2011-10-07 | 新岩藻糖基转移酶及它们的应用 |
Country Status (15)
Country | Link |
---|---|
US (1) | US9441211B2 (zh) |
EP (2) | EP2944690B1 (zh) |
JP (1) | JP6097691B2 (zh) |
CN (1) | CN103201380B (zh) |
AU (1) | AU2011315656B2 (zh) |
BR (1) | BR112013008822A8 (zh) |
DK (2) | DK2944690T3 (zh) |
ES (1) | ES2663627T3 (zh) |
MX (1) | MX344691B (zh) |
MY (1) | MY189569A (zh) |
NZ (1) | NZ609127A (zh) |
PL (1) | PL2944690T3 (zh) |
RU (1) | RU2642307C2 (zh) |
SG (1) | SG189300A1 (zh) |
WO (1) | WO2012049083A2 (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105695537A (zh) * | 2016-02-29 | 2016-06-22 | 福建农林大学 | 一种降血糖及调节肠道菌群的糖基化浒苔寡糖制备方法 |
CN106434590A (zh) * | 2016-12-13 | 2017-02-22 | 福建农林大学 | 一种岩藻糖基转移酶及其基因工程菌和应用 |
CN106434591A (zh) * | 2016-12-13 | 2017-02-22 | 福建农林大学 | 一种岩藻糖基转移酶及其应用 |
CN110662842A (zh) * | 2017-04-21 | 2020-01-07 | 首尔大学校产学协力团 | 利用谷氨酸棒状杆菌的3’-岩藻糖基乳糖的生产方法 |
CN111683665A (zh) * | 2017-11-30 | 2020-09-18 | 格礼卡姆股份公司 | 用于微生物群调节的人乳寡糖及其合成组合物 |
CN113195509A (zh) * | 2018-12-18 | 2021-07-30 | 因比奥斯公司 | 生产3-岩藻糖基乳糖和转化乳糖的α-1,3-岩藻糖基转移酶 |
CN115058465A (zh) * | 2022-06-30 | 2022-09-16 | 山东大学 | 一种岩藻糖基化软骨素及其制备方法和应用 |
CN117187206A (zh) * | 2023-05-19 | 2023-12-08 | 无锡特殊食品与营养健康研究院有限公司 | 肠道微生物来源的岩藻糖基转移酶及其应用 |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013130773A2 (en) | 2012-02-29 | 2013-09-06 | Ethicon Endo-Surgery, Inc. | Compositions of microbiota and methods related thereto |
EP2845905B8 (en) | 2013-09-10 | 2021-07-14 | Chr. Hansen HMO GmbH | Production of oligosaccharides |
ES2701163T3 (es) | 2014-01-20 | 2019-02-21 | Jennewein Biotechnologie Gmbh | Procedimiento para la purificación eficiente de oligosacáridos de la leche humana (HMO) neutros a partir de la fermentación microbiana |
EP3461890A1 (en) | 2014-03-31 | 2019-04-03 | Jennewein Biotechnologie GmbH | Total fermentation of oligosaccharides |
KR101718681B1 (ko) | 2014-06-23 | 2017-03-22 | 서울대학교산학협력단 | 가용성 단백질 발현량 및 활성이 증대된 헬리코박터 파일로리 유래 α-1,3 푸코실 전달효소의 유전자와 단백질 및 α-1,3 푸코실올리고당 생산에의 응용 |
CA2960835A1 (en) * | 2014-09-09 | 2016-03-17 | Glycosyn LLC | Alpha (1,3) fucosyltransferases for use in the production of fucosylated oligosaccharides |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
EP3212001A4 (en) | 2014-10-31 | 2018-04-25 | Whole Biome Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
EP3050973A1 (en) * | 2015-01-30 | 2016-08-03 | Jennewein Biotechnologie GmbH | Fermentation process for producing monosaccharides in free form from nucleotide-activated sugars |
KR101794971B1 (ko) * | 2016-02-02 | 2017-11-08 | 서울대학교 산학협력단 | α-1,3-푸코실락토오즈의 대량 생산 방법 |
EP3315610B1 (en) | 2016-10-29 | 2020-12-16 | Jennewein Biotechnologie GmbH | Process for the production of fucosylated oligosaccharides |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
KR101794972B1 (ko) * | 2017-01-26 | 2017-11-08 | 서울대학교 산학협력단 | α-1,3-푸코실락토오즈의 대량 생산 방법 |
EP3425052A1 (en) | 2017-07-07 | 2019-01-09 | Jennewein Biotechnologie GmbH | Fucosyltransferases and their use in producing fucosylated oligosaccharides |
WO2019046646A1 (en) | 2017-08-30 | 2019-03-07 | Whole Biome Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS |
EP3751003A1 (en) | 2019-06-12 | 2020-12-16 | Jennewein Biotechnologie GmbH | Production of fucosylated oligosaccharides in bacillus |
JPWO2022168992A1 (zh) | 2021-02-08 | 2022-08-11 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001023398A1 (en) * | 1999-09-28 | 2001-04-05 | Carbion Oy | Novel fucosylated oligosaccharides and process for their preparation |
CN1360633A (zh) * | 1999-02-18 | 2002-07-24 | 弗里德里希·阿尔特曼 | 岩藻糖基转移酶基因 |
US20060234354A1 (en) * | 1998-01-15 | 2006-10-19 | Cytel Corporation | Preparation of fucosylated oligosaccharides |
WO2010070104A1 (en) * | 2008-12-19 | 2010-06-24 | Jennewein Biotechnologie Gmbh | Synthesis of fucosylated compounds |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2125092C1 (ru) * | 1991-10-15 | 1999-01-20 | Дзе Скриппс Рисерч Инститьют | Способ получения фукозилированного углевода, способ получения фукозилированной сиалилированной углеводной молекулы, реакционная система in vitro |
EP0621337A1 (en) * | 1993-01-25 | 1994-10-26 | American Cyanamid Company | Codon optimized DNA sequence for insect toxin AaIT |
US5922577A (en) * | 1995-04-11 | 1999-07-13 | Cytel Corporation | Enzymatic synthesis of glycosidic linkages |
US5728554A (en) | 1995-04-11 | 1998-03-17 | Cytel Corporation | Enzymatic synthesis of glycosidic linkages |
US6399337B1 (en) * | 1997-06-06 | 2002-06-04 | The Governors Of The University Of Alberta | α1,3-fucosyltransferase |
TWI237527B (en) | 2001-11-06 | 2005-08-01 | Delta Optoelectronics Inc | Driver apparatus for a flat-type lamp and driving method for the same |
US7326770B2 (en) * | 2004-01-22 | 2008-02-05 | Neose Technologies, Inc. | H. pylori fucosyltransferases |
JP2008507297A (ja) * | 2004-07-26 | 2008-03-13 | エンゾン ファーマシューティカルズ,インコーポレーテッド | 最適化されたインターフェロンβ遺伝子 |
EP2366787B1 (en) | 2006-01-13 | 2019-12-11 | The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services | Codon optimized IL-15 and IL-15R-Alpha genes for expression in mammalian cells |
WO2008143713A2 (en) | 2006-12-22 | 2008-11-27 | Dow Agrosciences Llc | Plant-made west nile virus (wnv) vaccines, vectors and plant codon optimized sequences |
JP2009095264A (ja) * | 2007-10-15 | 2009-05-07 | Univ Of Ryukyus | コドン最適化ロイヤリシン遺伝子 |
-
2010
- 2010-10-11 DK DK15169876.8T patent/DK2944690T3/en active
- 2010-10-11 EP EP15169876.8A patent/EP2944690B1/en active Active
- 2010-10-11 DK DK10187167.1T patent/DK2439264T3/en active
- 2010-10-11 PL PL15169876T patent/PL2944690T3/pl unknown
- 2010-10-11 EP EP10187167.1A patent/EP2439264B1/en active Active
- 2010-10-11 ES ES15169876.8T patent/ES2663627T3/es active Active
-
2011
- 2011-10-07 NZ NZ609127A patent/NZ609127A/en unknown
- 2011-10-07 BR BR112013008822A patent/BR112013008822A8/pt not_active Application Discontinuation
- 2011-10-07 JP JP2013532217A patent/JP6097691B2/ja active Active
- 2011-10-07 MX MX2013004055A patent/MX344691B/es active IP Right Grant
- 2011-10-07 SG SG2013025879A patent/SG189300A1/en unknown
- 2011-10-07 RU RU2013120902A patent/RU2642307C2/ru active
- 2011-10-07 WO PCT/EP2011/067538 patent/WO2012049083A2/en active Application Filing
- 2011-10-07 AU AU2011315656A patent/AU2011315656B2/en active Active
- 2011-10-07 MY MYPI2013700552A patent/MY189569A/en unknown
- 2011-10-07 CN CN201180049018.5A patent/CN103201380B/zh active Active
-
2013
- 2013-04-10 US US13/860,452 patent/US9441211B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060234354A1 (en) * | 1998-01-15 | 2006-10-19 | Cytel Corporation | Preparation of fucosylated oligosaccharides |
US7247456B2 (en) * | 1998-01-15 | 2007-07-24 | Neose Technologies, Inc. | Preparation of fucosylated oligosaccharides |
CN1360633A (zh) * | 1999-02-18 | 2002-07-24 | 弗里德里希·阿尔特曼 | 岩藻糖基转移酶基因 |
WO2001023398A1 (en) * | 1999-09-28 | 2001-04-05 | Carbion Oy | Novel fucosylated oligosaccharides and process for their preparation |
WO2010070104A1 (en) * | 2008-12-19 | 2010-06-24 | Jennewein Biotechnologie Gmbh | Synthesis of fucosylated compounds |
Non-Patent Citations (5)
Title |
---|
CERDENO-TARRAGA,A.M. ET AL.: "CAH09151.1 glycosyltransferase [Bacteroides fragilis NCTC 9343]", 《GENBANK》 * |
CERDENO-TARRAGA,A.M. ET AL.: "CR626927.1 Bacteroides fragilis NCTC 9343, complete genome", 《GENBANK》 * |
CERDENO-TARRAGA,A.M. ET AL.: "Extensive DNA inversions in the B. fragilis genome control variable", 《SCIENCE》 * |
LUCAS,S. ET AL.: "YP_001877377 hypothetical protein Amuc_0760 [Akkermansia muciniphila ATCC BAA-835]", 《GENBANK》 * |
TOMOMI KUWAHARA. ET AL.: "Genomic analysis of Bacteroides fragilis reveals extensive DNA inversions regulating cell surface adaptation", 《PNAS》 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105695537A (zh) * | 2016-02-29 | 2016-06-22 | 福建农林大学 | 一种降血糖及调节肠道菌群的糖基化浒苔寡糖制备方法 |
CN105695537B (zh) * | 2016-02-29 | 2019-11-19 | 福建农林大学 | 一种降血糖及调节肠道菌群的糖基化浒苔寡糖制备方法 |
CN106434590A (zh) * | 2016-12-13 | 2017-02-22 | 福建农林大学 | 一种岩藻糖基转移酶及其基因工程菌和应用 |
CN106434591A (zh) * | 2016-12-13 | 2017-02-22 | 福建农林大学 | 一种岩藻糖基转移酶及其应用 |
CN110662842A (zh) * | 2017-04-21 | 2020-01-07 | 首尔大学校产学协力团 | 利用谷氨酸棒状杆菌的3’-岩藻糖基乳糖的生产方法 |
CN110662842B (zh) * | 2017-04-21 | 2023-03-21 | 首尔大学校产学协力团 | 利用谷氨酸棒状杆菌的3-岩藻糖基乳糖的生产方法 |
CN111683665A (zh) * | 2017-11-30 | 2020-09-18 | 格礼卡姆股份公司 | 用于微生物群调节的人乳寡糖及其合成组合物 |
CN113195509A (zh) * | 2018-12-18 | 2021-07-30 | 因比奥斯公司 | 生产3-岩藻糖基乳糖和转化乳糖的α-1,3-岩藻糖基转移酶 |
CN115058465A (zh) * | 2022-06-30 | 2022-09-16 | 山东大学 | 一种岩藻糖基化软骨素及其制备方法和应用 |
CN117187206A (zh) * | 2023-05-19 | 2023-12-08 | 无锡特殊食品与营养健康研究院有限公司 | 肠道微生物来源的岩藻糖基转移酶及其应用 |
Also Published As
Publication number | Publication date |
---|---|
PL2944690T3 (pl) | 2018-05-30 |
EP2439264A1 (en) | 2012-04-11 |
NZ609127A (en) | 2014-10-31 |
MX344691B (es) | 2016-12-29 |
ES2663627T3 (es) | 2018-04-16 |
US20130217068A1 (en) | 2013-08-22 |
RU2642307C2 (ru) | 2018-01-24 |
SG189300A1 (en) | 2013-05-31 |
EP2944690A3 (en) | 2016-03-09 |
RU2013120902A (ru) | 2014-11-20 |
JP6097691B2 (ja) | 2017-03-15 |
MX2013004055A (es) | 2013-06-05 |
JP2013541952A (ja) | 2013-11-21 |
MY189569A (en) | 2022-02-17 |
EP2944690A2 (en) | 2015-11-18 |
CN103201380B (zh) | 2018-07-24 |
WO2012049083A3 (en) | 2012-06-14 |
BR112013008822A8 (pt) | 2023-01-31 |
AU2011315656B2 (en) | 2016-01-21 |
EP2439264B1 (en) | 2015-06-03 |
DK2439264T3 (en) | 2015-08-03 |
EP2944690B1 (en) | 2017-12-20 |
WO2012049083A2 (en) | 2012-04-19 |
AU2011315656A1 (en) | 2013-05-02 |
BR112013008822A2 (pt) | 2017-09-19 |
DK2944690T3 (en) | 2018-04-03 |
US9441211B2 (en) | 2016-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103201380A (zh) | 新岩藻糖基转移酶及它们的应用 | |
CN103328630A (zh) | 新型岩藻糖基转移酶及其应用 | |
US20220002773A1 (en) | Production of 3-fucosyllactose and lactose converting alpha-1,3-fucosyltransferase enzymes | |
CA2639150C (en) | Construction of new variants of dextransucrase dsr-s by genetic engineering | |
US9938549B2 (en) | Process for producing monosaccharides | |
WO2019020707A1 (en) | SIALYL-TRANSFERASES AND THEIR USE IN THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | |
WO2015150328A1 (en) | Total fermentation of oligosaccharides | |
CN113151211B (zh) | 一种α-1,3-岩藻糖基转移酶突变体及利用该突变体制备3-岩藻糖基乳糖的应用 | |
JP2018503383A (ja) | ヌクレオチドにより活性化された糖から遊離形の単糖を生産するための発酵法 | |
Bastida et al. | Heterologous Over‐expression of α‐1, 6‐Fucosyltransferase from Rhizobium sp.: Application to the Synthesis of the Trisaccharide β‐d‐GlcNAc (1→ 4)‐[α‐l‐Fuc‐(1→ 6)]‐d‐GlcNAc, Study of the Acceptor Specificity and Evaluation of Polyhydroxylated Indolizidines as Inhibitors | |
WO2020260249A1 (en) | Enzymatic production of levan-based, prebiotic fructooligosaccharides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1181814 Country of ref document: HK |
|
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Julia Packett Inventor after: Eric Huffner Inventor after: Stefan Jennewyne Inventor before: Julia Packett Inventor before: Eric Huffner Inventor before: Stefan Jennewyne Inventor before: Elling Lothar Inventor before: Leonie Engels |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: PARKOT JULIA HUEFNER ERIC JENNEWEIN STEFAN ELLING LOTHAR ENGELS LEONIE TO: PARKOT JULIA HUEFNER ERIC JENNEWEIN STEFAN |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: Bright Bach, Rhine, Germany Patentee after: Kohansen breast milk oligosaccharides Co.,Ltd. Address before: Bright Bach, Rhine, Germany Patentee before: JENNEWEIN BIOTECHNOLOGIE GmbH |
|
CP01 | Change in the name or title of a patent holder |